Symbol="TTNP"
AssetType="Common Stock"
Name="Titan Pharmaceuticals Inc"
Description="Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapies for the treatment of chronic diseases. The company is headquartered in South San Francisco, California."
CIK="910267"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="7835500"
EBITDA="-8756000"
PERatio="None"
PEGRatio="0"
BookValue="-0.021"
DividendPerShare="0"
DividendYield="0"
EPS="-0.63"
RevenuePerShareTTM="0.032"
ProfitMargin="0"
OperatingMarginTTM="-20.29"
ReturnOnAssetsTTM="-0.94"
ReturnOnEquityTTM="-2.468"
RevenueTTM="463000"
GrossProfitTTM="-4365000"
DilutedEPSTTM="-0.63"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.49"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="22.8"
PriceToBookRatio="4.038"
EVToRevenue="7.83"
EVToEBITDA="-1.02"
Beta="1.069"
num_52WeekHigh="1.59"
num_52WeekLow="0.51"
num_50DayMovingAverage="0.698"
num_200DayMovingAverage="0.841"
SharesOutstanding="15016300"
DividendDate="2020-12-01"
ExDividendDate="None"
symbol="TTNP"
open="0.59"
high="0.70"
low="0.55"
price="0.59"
volume="3530701.00"
latest_trading_day="2023-07-27"
previous_close="0.52"
change="0.07"
change_percent="13.0678%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="83"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="17"
Volume_recent_avg="55039"
Change_recent_avg="0.01"
Delta_recent_avg="0.04"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="17"
Aroon_momentum_negative="83"
image_negative_thumbnail_id_1="124"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0052.jpeg"
image_negative_thumbnail_id_2="1092"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0125.jpeg"
image_neutral_thumbnail_id_1="558"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_neutral_thumbnail_id_2="542"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_positive_thumbnail_id_1="1000"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0162.jpeg"
image_positive_thumbnail_id_2="615"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
